The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
Abstract
Breast carcinogenesis is a multistep process involving both genetic and epigenetic changes. Since epigenetic changes like histone modifications are potentially reversible processes, much effort has been directed toward understanding this mechanism with the goal of finding novel therapies as well as more refined diagnostic and prognostic tools in breast cancer. Lysine-specific demethylase 1 (LSD1) plays a key role in the regulation of gene expression by removing the methyl groups from methylated lysine 4 of histone H3 and lysine 9 of histone H3. LSD1 is essential for mammalian development and involved in many biological processes. Considering recent evidence that LSD1 is involved in carcinogenesis, we investigated the role of LSD1 in breast cancer. Therefore, we developed an enzyme-linked immunosorbent assay to determine LSD1 protein levels in tissue specimens of breast cancer and measured very high LSD1 levels in estrogen receptor (ER)-negative tumors. Pharmacological LSD1 inhibition resulted in growth inhibition of breast cancer cells. Knockdown of LSD1 using small interfering RNA approach induced regulation of several proliferation-associated genes like p21, ERBB2 and CCNA2. Additionally, we found that LSD1 is recruited to the promoters of these genes. In summary, our data indicate that LSD1 may provide a predictive marker for aggressive biology and a novel attractive therapeutic target for treatment of ER-negative breast cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Histone demethylation by a family of JmjC domain-containing proteins
Tsukada, Y.-I., Fang, J., Erdjument-Bromage, H., Warren, M. E., Borchers, C. H., Tempst, P., & Zhang, Y. (2006) · Nature · doi:10.1038/nature04433 · Cited by 2,163
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
Metzger, E., Wissmann, M., Yin, N., Müller, J. M., Schneider, R., Peters, A. H. F. M., Günther, T., Buettner, R., & Schüle, R. (2005) · Nature · doi:10.1038/nature04020 · Cited by 1,733
Self-citationReversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases
Whetstine, J. R., Nottke, A., Lan, F., Huarte, M., Smolikov, S., Chen, Z., Spooner, E., Li, E., Zhang, G., Colaiacovo, M., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.028 · Cited by 1,040
Regulation of LSD1 Histone Demethylase Activity by Its Associated Factors
Shi, Y.-J., Matson, C., Lan, F., Iwase, S., Baba, T., & Shi, Y. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.027 · Cited by 886
Targeting polo-like kinase 1 for cancer therapy
Strebhardt, K., & Ullrich, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1841 · Cited by 841
Yamane, K., Toumazou, C., Tsukada, Y.-I., Erdjument-Bromage, H., Tempst, P., Wong, J., & Zhang, Y. (2006) · Cell · doi:10.1016/j.cell.2006.03.027 · Cited by 837
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
Wang, J., Hevi, S., Kurash, J. K., Lei, H., Gay, F., Bajko, J., Su, H., Sun, W., Chang, H., Xu, G., et al. (2009) · Nature Genetics · doi:10.1038/ng.268 · Cited by 815
An epigenetic road map for histone lysine methylation
Lachner, M., O'Sullivan, R. J., & Jenuwein, T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00493 · Cited by 630
The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36
Klose, R. J., Yamane, K., Bae, Y., Zhang, D., Erdjument-Bromage, H., Tempst, P., Wong, J., & Zhang, Y. (2006) · Nature · doi:10.1038/nature04853 · Cited by 627
Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression
Wissmann, M., Yin, N., Müller, J. M., Greschik, H., Fodor, B. D., Jenuwein, T., Vogler, C., Schneider, R., Günther, T., Buettner, R., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1546 · Cited by 598
Self-citationOpposing LSD1 complexes function in developmental gene activation and repression programmes
Wang, J., Scully, K., Zhu, X., Cai, L., Zhang, J., Prefontaine, G. G., Krones, A., Ohgi, K. A., Zhu, P., Garcia-Bassets, I., et al. (2007) · Nature · doi:10.1038/nature05671 · Cited by 579
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
Cui, X., Schiff, R., Arpino, G., Osborne, C. K., & Lee, A. V. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.004 · Cited by 514
Kahl, P., Gullotti, L., Heukamp, L. C., Wolf, S., Friedrichs, N., Vorreuther, R., Solleder, G., Bastian, P. J., Ellinger, J., Metzger, E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1570 · Cited by 469
Self-citationSchulte, J. H., Lim, S., Schramm, A., Friedrichs, N., Koster, J., Versteeg, R., Ora, I., Pajtler, K., Klein-Hitpass, L., Kuhfittig-Kulle, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1735 · Cited by 445
Self-citationHistone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive Medications
Lee, M. G., Wynder, C., Schmidt, D. M., McCafferty, D. G., & Shiekhattar, R. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.004 · Cited by 438
Garcia-Bassets, I., Kwon, Y.-S., Telese, F., Prefontaine, G. G., Hutt, K. R., Cheng, C. S., Ju, B.-G., Ohgi, K. A., Wang, J., Escoubet-Lozach, L., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.038 · Cited by 437
Goidin, D., Mamessier, A., Staquet, M.-J., Schmitt, D., & Berthier-Vergnes, O. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5171 · Cited by 394
Huang, Y., Greene, E., Murray Stewart, T., Goodwin, A. C., Baylin, S. B., Woster, P. M., & Casero, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700720104 · Cited by 292
Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., He, K., Sridhara, R., Abraham, S., Booth, B. P., Verbois, L., Morse, D. E., Jee, J. M., Pope, S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2672 · Cited by 262
Lo, P.-K., & Sukumar, S. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.12.1879 · Cited by 184
LSD1: oxidative chemistry for multifaceted functions in chromatin regulation
Forneris, F., Binda, C., Battaglioli, E., & Mattevi, A. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.01.003 · Cited by 165
Ramachandran, C., Rodriguez, S., Ramachandran, R., Nair, P., Fonseca, H. B., Khatib, Z. A., Escalon, E., & Melnick, S. J. (2005) · PubMed · Cited by 150
Scoumanne, A., & Chen, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701023200 · Cited by 144
O’Brien, S. L., Fagan, A., Fox, E., Millikan, R. C., Culhane, A. C., Brennan, D. J., McCann, A. H., Hegarty, S. M., Moyna, S., Duffy, M. J., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22413 · Cited by 120
Activator protein‐2 in carcinogenesis with a special reference to breast cancer—A mini review
Pellikainen, J. M., & Kosma, V. (2007) · International Journal of Cancer · doi:10.1002/ijc.22648 · Cited by 115
Sunami, E., Shinozaki, M., Sim, M., Nguyen, S. L., Vu, A., Giuliano, A. E., & Hoon, D. S. �. (2008) · Breast Cancer Research · doi:10.1186/bcr2098 · Cited by 111
Prognostic impact of Skp2 and p27 in human breast cancer
Traub, F., Mengel, M., Lück, H. J., Kreipe, H. H., & von Wasielewski, R. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9202-3 · Cited by 80
Gartenhaus, R. B., Wang, P., & Hoffmann, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.265 · Cited by 77
Osthus, R. C., Karim, B. O., Prescott, J. E., Smith, B. D., McDevitt, M. A., Huso, D. L., & Dang, C. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0536 · Cited by 76
The genomic profile of HER2‐amplified breast cancers: the influence of ER status
Marchiò, C., Natrajan, R., Shiu, K., Lambros, M., Rodriguez‐Pinilla, S., Tan, D., Lord, C. J., Hungermann, D., Fenwick, K., Tamber, N., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2423 · Cited by 75
Enhancer of Zeste 2 as a Marker of Preneoplastic Progression in the Breast
Ding, L., & Kleer, C. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2384 · Cited by 62
McIntyre, E., Blackburn, E., Brown, P. J., Johnson, C. G., & Gullick, W. J. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0536-5 · Cited by 55
Husdal, A., Bukholm, G., & Bukholm, I. R. K. (2006) · Analytical Cellular Pathology · doi:10.1155/2006/721919 · Cited by 54
Carcinogen-induced histone alteration in normal human mammary epithelial cells
Bradley, C., van der Meer, R., Roodi, N., Yan, H., Chandrasekharan, M. B., Sun, Z.-W., Mernaugh, R. L., & Parl, F. F. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm100 · Cited by 44
Chen, Q., Liang, D., Yang, T., Leone, G. W., & Overbeek, P. A. (2004) · Developmental Neuroscience · doi:10.1159/000082285 · Cited by 18
Frączek, M., Woźniak, Z., Ramsey, D., Zatoński, T., & Kr̨ecicki, T. (2008) · Acta Oto-Laryngologica · doi:10.1080/00016480701487742 · Cited by 7
Cited by
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
The epigenetics of epithelial-mesenchymal plasticity in cancer
Tam, W. L., & Weinberg, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3336 · Cited by 1,163
Histone Modifications and Cancer
Audia, J. E., & Campbell, R. M. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019521 · Cited by 1,024
Molecular mechanisms and potential functions of histone demethylases
Kooistra, S. M., & Helin, K. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3327 · Cited by 878
Schenk, T., Chen, W. C., Göllner, S., Howell, L., Jin, L., Hebestreit, K., Klein, H.-U., Popescu, A. C., Burnett, A., Mills, K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2661 · Cited by 672
Metadata
- Authors
- Lim, S., Janzer, A., Becker, A., Zimmer, A., Schüle, R., Buettner, R., & Kirfel, J.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-12-30
- Volume
- 31
- Issue
- 3
- Pages
- 512-520
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2137678309
- Cited by
- 470
- References
- 42
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.